U.S. Markets closed

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
290.48+34.78 (+13.60%)
At close: 3:00PM CST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in CNY

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3344.70
52 Week Low 312.60
50-Day Moving Average 3252.29
200-Day Moving Average 3226.86

Share Statistics

Avg Vol (3 month) 31.68M
Avg Vol (10 day) 3855.51k
Shares Outstanding 5433.6M
Implied Shares Outstanding 6N/A
Float 71.93M
% Held by Insiders 188.46%
% Held by Institutions 11.50%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.25
Trailing Annual Dividend Yield 30.10%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2020
Most Recent Quarter (mrq)Dec 31, 2020

Profitability

Profit Margin 28.76%
Operating Margin (ttm)30.78%

Management Effectiveness

Return on Assets (ttm)15.98%
Return on Equity (ttm)32.77%

Income Statement

Revenue (ttm)2.35B
Revenue Per Share (ttm)5.63
Quarterly Revenue Growth (yoy)113.60%
Gross Profit (ttm)1.88B
EBITDA 807.18M
Net Income Avi to Common (ttm)677M
Diluted EPS (ttm)1.62
Quarterly Earnings Growth (yoy)150.90%

Balance Sheet

Total Cash (mrq)814.22M
Total Cash Per Share (mrq)1.88
Total Debt (mrq)77.66M
Total Debt/Equity (mrq)3.01
Current Ratio (mrq)2.39
Book Value Per Share (mrq)5.89

Cash Flow Statement

Operating Cash Flow (ttm)468.21M
Levered Free Cash Flow (ttm)-217.55M